• Optomed’s board resolved a targeted, non-cash share issue to settle the equity portion of 2026 board remuneration.
• 42,614 new shares to be issued free of consideration to board members under the mandate granted by the 2026 annual general meeting.
• Registration of the new shares expected on Aug. 24, 2026; dividend and shareholder rights to start upon registration.
• Admission to trading on Nasdaq Helsinki’s regulated market targeted for Aug. 25, 2026; total shares to rise to 21,495,911.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optomed plc published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.